HCSG

Healthcare Services Group Inc

Add to Watchlist

Advanced Chart

14.440

+0.05(0.347%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

14.520

Open

14.470

VWAP

14.33

Vol

372.26K

Mkt Cap

1.04B

Low

14.210

Amount

5.34M

EV/EBITDA(TTM)

41.34

Total Shares

72.41M

955.53M

EV/OCF(TTM)

9.87

P/S(TTM)

0.60

Healthcare Services Group, Inc. is engaged in managing housekeeping, laundry, dining, and nutritional services within the healthcare industry. Its segments include housekeeping, laundry, linen and other services (Housekeeping), and dietary department services (Dietary). Housekeeping segment consists of managing its customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the customers’ facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the customers’ facilities. Dietary segment consists of managing its customers’ dietary departments, which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents. It also offers clinical consulting services to its dietary customers.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

473.85M

+5.85%

0.238

+3.36%

466.24M

+6.49%

0.221

+37.16%

460.43M

+7.54%

0.195

+2.74%

Estimates Revision

The market is revising Upward the revenue expectations for Healthcare Services Group, Inc. (HCSG) for FY2025, with the revenue forecasts being adjusted by 1.48% over the past three months. During the same period, the stock price has changed by -0.35%.

Revenue Estimates for FY2025

Revise Upward

+1.48%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+4.54%

In Past 3 Month

Stock Price

Go Down

-0.35%

In Past 3 Month

5 Analyst Rating

17.73% Upside

Wall Street analysts forecast HCSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HCSG is 17.00 USD with a low forecast of 15.00 USD and a high forecast of 19.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

2 Hold

0 Sell

Moderate Buy

17.73% Upside

Current: 14.440

Low

15.00

Averages

17.00

High

19.00

17.73% Upside

Current: 14.440

Low

15.00

Averages

17.00

High

19.00

Macquarie

Neutral -> Outperform

upgrade

$15 -> $16

2025-07-28

Reason

Macquarie

Price Target

$15 -> $16

2025-07-28

upgrade

Neutral -> Outperform

Reason

Macquarie upgraded Healthcare Services to Outperform from Neutral with a price target of $16, up from $15. The firm sees upside from stable industry fundamentals, growth momentum, and enhanced capital return. Macquarie also believes the accelerating growth trend is sustainable as the company executed well on sales and retentions despite noise around Genesis.

Baird

Neutral

maintain

$13 -> $15

2025-07-24

Reason

Baird

Price Target

$13 -> $15

2025-07-24

maintain

Neutral

Reason

Baird raised the firm's price target on Healthcare Services to $15 from $13 and keeps a Neutral rating on the shares. The firm updated its model following Q2 results and noted the recent Big Beautiful Bill impact will take some time.

UBS

AJ Rice

Neutral -> Buy

upgrade

$12 -> $15

2025-04-24

Reason

UBS

AJ Rice

Price Target

$12 -> $15

2025-04-24

upgrade

Neutral -> Buy

Reason

UBS analyst AJ Rice upgraded Healthcare Services to Buy from Neutral with a price target of $15, up from $12. The firm believes the company will see an acceleration in revenue growth to 5.7% in 2025 as it benefits from an improving nursing home industry, strong retention, new customer additions, and cross-selling opportunities. Nursing homes represent the majority of Healthcare Services' overall business and is an industry that is recovering from a challenged environment during the pandemic, the analyst tells investors in a research note. UBS says the company's "discounted valuation" offers an attractive entry point.

Baird

Andrew Wittmann

Neutral

maintain

$12 -> $13

2025-04-24

Reason

Baird

Andrew Wittmann

Price Target

$12 -> $13

2025-04-24

maintain

Neutral

Reason

Baird analyst Andrew Wittmann raised the firm's price target on Healthcare Services to $13 from $12 and keeps a Neutral rating on the shares. The firm updated its model following Q1 results and said things are heading in the right direction.

Benchmark

Bill Sutherland

Strong Buy

Reiterates

$17

2024-12-19

Reason

Benchmark

Bill Sutherland

Price Target

$17

2024-12-19

Reiterates

Strong Buy

Reason

Group Luncheon Meeting with Management to be held in New York on December 10 at 12 pm hosted by Benchmark.

Macquarie

Tao Qiu

Hold

Initiates

$13

2024-12-16

Reason

Macquarie

Tao Qiu

Price Target

$13

2024-12-16

Initiates

Hold

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Healthcare Services Group Inc (HCSG.O) is 16.27, compared to its 5-year average forward P/E of 21.80. For a more detailed relative valuation and DCF analysis to assess Healthcare Services Group Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair

5Y Average PE

21.80

Current PE

16.27

Overvalued PE

30.58

Undervalued PE

13.02

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

11.74

Current EV/EBITDA

8.04

Overvalued EV/EBITDA

16.02

Undervalued EV/EBITDA

7.45

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

0.72

Current PS

0.53

Overvalued PS

1.02

Undervalued PS

0.42